Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Thall

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|January 24, 2019
Bayesian variable selection based on clinical relevance weights in small sample studies-Application to colon cancerSandrine Boulet, Moreno Ursino, Peter Thall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized studySimrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
Statistical Methods in Medical Research|April 10, 2019
Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer dataSandrine Boulet, Moreno Ursino, Peter Thall, et al.
Anticancer Research|July 9, 2011
Induction treatment for diffuse intrinsic pontine glioma, experience of M.D. Anderson Cancer CenterJohannes E Wolff, Michael Rytting, Tribhawa Vats, et al.
Cancer|November 17, 2011
Durable remission with salvage second autotransplants in patients with multiple myelomaNina Shah, Fraz Ahmed, Qaiser Bashir, et al.
Annals of Surgical Oncology|October 28, 2008
A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosisJohn C McAuliffe, Kelly K Hunt, Alexander J F Lazar, et al.
Cancer|October 10, 2006
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinomaNizar M Tannir, Lorenzo Cohen, Xuemei Wang, et al.
Cancer|January 7, 2010
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancerStacy L Moulder, Frankie A Holmes, Anthony W Tolcher, et al.
British Journal of Haematology|May 20, 2003
A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expressionFrancis J Giles, B Nebiyou Bekele, Susan O'Brien, et al.
Annals of Surgery|April 2, 2020
Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung SurgeryDavid Rice, Andrea Rodriguez-Restrepo, Gabriel Mena, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|January 24, 2019
Bayesian variable selection based on clinical relevance weights in small sample studies-Application to colon cancerSandrine Boulet, Moreno Ursino, Peter Thall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2012
Dose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized studySimrit Parmar, Gabriela Rondon, Marcos de Lima, et al.
Statistical Methods in Medical Research|April 10, 2019
Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer dataSandrine Boulet, Moreno Ursino, Peter Thall, et al.
Anticancer Research|July 9, 2011
Induction treatment for diffuse intrinsic pontine glioma, experience of M.D. Anderson Cancer CenterJohannes E Wolff, Michael Rytting, Tribhawa Vats, et al.
Cancer|November 17, 2011
Durable remission with salvage second autotransplants in patients with multiple myelomaNina Shah, Fraz Ahmed, Qaiser Bashir, et al.
Annals of Surgical Oncology|October 28, 2008
A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosisJohn C McAuliffe, Kelly K Hunt, Alexander J F Lazar, et al.
Cancer|October 10, 2006
Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-alpha-2b: results of a randomized phase II trial of low-dose versus intermediate-dose interferon-alpha-2b in patients with metastatic renal cell carcinomaNizar M Tannir, Lorenzo Cohen, Xuemei Wang, et al.
Cancer|January 7, 2010
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancerStacy L Moulder, Frankie A Holmes, Anthony W Tolcher, et al.
British Journal of Haematology|May 20, 2003
A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expressionFrancis J Giles, B Nebiyou Bekele, Susan O'Brien, et al.
Annals of Surgery|April 2, 2020
Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung SurgeryDavid Rice, Andrea Rodriguez-Restrepo, Gabriel Mena, et al.
Pageof 2